You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper

Article info

Article menu

Download PDFPDF

Pulmonary vascular disease
Review
Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper

Authors

  • Paul Abraham Intensive Care Unit, Geneva University Hospitals, Geneva, SwitzerlandGeneva Hemodynamic Research Group, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Diego A Arroyo Intensive Care Unit, Geneva University Hospitals, Geneva, SwitzerlandGeneva Hemodynamic Research Group, Geneva, SwitzerlandDepartment of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland PubMed articlesGoogle scholar articles
  • Raphael Giraud Intensive Care Unit, Geneva University Hospitals, Geneva, SwitzerlandGeneva Hemodynamic Research Group, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Henri Bounameaux Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Karim Bendjelid Intensive Care Unit, Geneva University Hospitals, Geneva, SwitzerlandGeneva Hemodynamic Research Group, Geneva, Switzerland PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Karim Bendjelid; karim.bendjelid{at}hcuge.ch
View Full Text

Citation

Abraham P, Arroyo DA, Giraud R, et al
Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper
Open Heart 2018;5:e000735. doi: 10.1136/openhrt-2017-000735

Publication history

  • Received October 11, 2017
  • Revision received January 23, 2018
  • Accepted January 30, 2018
  • First published February 26, 2018.
Online issue publication 
April 30, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/